Readystate Asset Management LP Sells 5,524 Shares of iShares Global Healthcare ETF $IXJ

Readystate Asset Management LP lessened its stake in iShares Global Healthcare ETF (NYSEARCA:IXJ) by 70.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,298 shares of the company’s stock after selling 5,524 shares during the quarter. Readystate Asset Management LP’s holdings in iShares Global Healthcare ETF were worth $226,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Arax Advisory Partners bought a new stake in iShares Global Healthcare ETF during the fourth quarter worth $31,000. Franklin Resources Inc. grew its position in shares of iShares Global Healthcare ETF by 80.0% in the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock valued at $31,000 after acquiring an additional 160 shares during the period. RMG Wealth Management LLC acquired a new position in shares of iShares Global Healthcare ETF during the 1st quarter worth about $47,000. Triumph Capital Management acquired a new position in shares of iShares Global Healthcare ETF during the 3rd quarter worth about $53,000. Finally, EFG International AG acquired a new position in shares of iShares Global Healthcare ETF during the 4th quarter worth about $78,000.

iShares Global Healthcare ETF Stock Down 2.9%

Shares of NYSEARCA IXJ opened at $101.91 on Wednesday. The business’s 50 day moving average price is $102.14 and its two-hundred day moving average price is $97.38. The company has a market cap of $4.16 billion, a PE ratio of 21.58 and a beta of 0.56. iShares Global Healthcare ETF has a twelve month low of $85.36 and a twelve month high of $107.68.

iShares Global Healthcare ETF Company Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.